{"Content: ":"Lonapegsomatropin, sold under the brand name Skytrofa, is a human growth hormone used for the treatment of growth hormone deficiency.[1] Lonapegsomatropin is a prodrug of somatropin.[1] Lonapegsomatropin was approved for medical use in the United States in August 2021.[1][2][4] Lonapegsomatropin is a growth hormone therapy indicated to treat growth hormone deficiency.[1][3] Antagonists: Pegvisomant  This hormonal preparation article is a stub. You can help Wikipedia by expanding it.","Title":"Lonapegsomatropin - Wikipedia","KeyID":"7983","URL":"https://en.wikipedia.org/wiki/Lonapegsomatropin"}